FDA Roundup: May 31, 2024

For Immediate Release: May 31, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA approved mRESVIA (Respiratory Syncytial Virus Vaccine) for the prevention of lower respiratory tract...

OMISIRGE

STN: 125738Proper Name: omidubicel-onlvTradename: OMISIRGEManufacturer: Gamida Cell Ltd.Indication: For the treatment of:Adults and pediatric patients 12 years and older with hematologic malignancies who are planned for umbilical cord blood transplantation following...
Close